✦ LIBER ✦

Nocturnal subcutaneous apomorphine infusion for severe insomnia in Parkinson's disease

✍ Scribed by Pedro J. Garcia Ruiz

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 108 KB
Volume: 21
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.20852

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dopaminergic responsiveness to apomorphi

Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease

✍ J. Vaamonde; M. R. Luquin; Dr. J. A. Obeso 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

## Abstract The aim of this study was to assess whether or not continuous infusion of lisuride in combination with intermittent levodopa‐carbidopa administration was associated with tolerance. Intravenous apomorphine was given to four patients before initiation of chronic treatment with subcutaneou

Subcutaneous apomorphine injections as a

Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease

✍ Stewart A. Factor; Diane L. Brown; Eric S. Molho 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 2 views

Comparative cognitive effects of bilater

Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease

✍ Montse Alegret; Francesc Valldeoriola; MaJosé Martí; Manuela Pilleri; Carme Junq 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

## Abstract Bilateral subthalamic deep brain stimulation (STN‐DBS) and continuous subcutaneous infusion of apomorphine (APM‐csi) can provide a comparable improvement on motor function in patients with advanced Parkinson's disease (PD), but the mechanisms by which both therapies exert their effects

Efficacy of long-term continuous subcuta

Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study

✍ Pedro J. García Ruiz; Ángel Sesar Ignacio; Begoña Ares Pensado; Alfonso Castro G 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 2 views

## Abstract Continuous subcutaneous apomorphine infusion (CSAI) is, at present, an alternative option for advanced Parkinson's disease (PD) with motor fluctuations. We studied the evolution of patients with PD and severe motor fluctuations long‐term treated with CSAI. We reviewed data from 82 patie

Continuous subcutaneous apomorphine ther

Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single-dose challenges

✍ Regina Katzenschlager; Andrew Hughes; Andrew Evans; Alice J. Manson; Marion Hoff 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

## Abstract Continuous subcutaneous (SC) infusion of the dopamine agonist apomorphine was shown in retrospective studies to improve drug‐induced dyskinesias in Parkinson's disease (PD). We prospectively assessed the antidyskinetic effect of continuous SC apomorphine therapy using subjective and obj

Beneficial effect of intranasal desmopre

Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson's disease

✍ Dr. Oksana Suchowersky; Sarah Furtado; Gina Rohs 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB

Patients with Parkinson's disease (PD) are known to experience autonomic nervous system dysfunction; this disruptive symptomatology includes urinary urgency, frequency, and nocturnal polyuria. Anticholinergic and tricyclic medications can be beneficial in controlling these urinary symptoms, but have